Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Cheng Yang

2PUBLICATIONS
30CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|May 13, 2026
Efficacy and Safety of Camrelizumab Plus Apatinib in Patients With Refractory Chordoma: A Phase II Clinical Trial.

|Dec 05, 2022
First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001.

Yan Zhou, Qingcheng Yang, Yang Dong

Pageof 1

Frequent Collaborators

1 joint publications

Yan Zhou

1 joint publications

Qingcheng Yang

1 joint publications

Yang Dong

1 joint publications

Tong Ji

1 joint publications

Bing Zhang

1 joint publications

Shuier Zheng

1 joint publications

Lina Tang

1 joint publications

Chenliang Zhou

1 joint publications

Guowei Qian

1 joint publications

Yujing Huang

Frequent Collaborators

1 joint publications

Yan Zhou

1 joint publications

Qingcheng Yang

1 joint publications

Yang Dong

1 joint publications

Tong Ji